Drug recalls, 2026-W06

FDA drug recalls, February 2 to 8, 2026

FDA posted 5 drug recalls the week of February 2, 2026: 3 Class II and 2 Class III.

License: openFDA publishes this file under CC0 1.0.

FDA sorts recalls by risk. Class I: using the product could cause serious health problems or death. Class II: it could cause temporary or reversible health problems. Class III: it is unlikely to cause health problems.

For pharmacies and practices

Get this every Monday

Rivvi pulls the FDA drug recalls posted in the last 7 days and sends you the list each Monday morning. Add the drugs you stock or prescribe and it flags any that match.

Watch recalls in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams, with the weekly watch turned on.

Recalls posted February 2 to 8, 2026

Class II · Posted February 4, 2026 · Started January 15, 2026 · Ongoing

methylprednisolone

Product: methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2
Firm: Greenstone Llc, Peapack, NJ
Reason: Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.
Lots: Lot # LG7675, Exp. Date Nov 2026
Quantity: 3456 cartons
Distribution: Nationwide within the United States
RxNorm: methylprednisolone (RxCUI 197971, 197973, 259966, 328161, 762675)
Recall number: D-0299-2026

Class III · Posted February 4, 2026 · Started December 26, 2025 · Ongoing

cetylpyridinium chloride

Product: parodontax (cetylpyridinium chloride)ACTIVE GUM HEALTH, Mouthwash, Mint. Net Wt 16.9 FL OZ (500 mL), Distributed by Haleon, Warren, NJ 07059. NDC 0135-0651-02
Firm: Haleon US Holdings LLC, Warren, NJ
Reason: Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for missing or illegible lot and expiration date coding on the bottles.
Lots: Lot #: 0665363, Exp 08/31/2027. Lot number and Exp Date may not appear on the 500 mL bottle.
Quantity: 84,764 bottles
Distribution: Nationwide in the USA
RxNorm: cetylpyridinium chloride (RxCUI 1100924)
Recall number: D-0297-2026

Class II · Posted February 4, 2026 · Started December 22, 2025 · Ongoing

water

Product: Sterile Water for Irrigation, 250 mL, Single-Dose Plastic Bottle, Rx Only, Baxter Healthcare Corporation Deerfield, IL 60015 NDC: 0338-0004-02.
Firm: Baxter Healthcare Corporation, Deerfield, IL
Reason: Presence of particulate matter: plastic particles from the bottle rim were observed floating into the solution
Lots: Lot #: G171359, expiry: 05/31/2027
Quantity: 125,496 bottles
Distribution: Nationwide
RxNorm: water (RxCUI 150985)
Recall number: D-0296-2026

Class II · Posted February 4, 2026 · Started December 19, 2025 · Ongoing

magnesium aluminosilicates, magnesium hydroxide, simethicone

Product: INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01
Firm: Sato Pharmaceutical Co., Ltd, Tokyo, Japan
Reason: Failed Disintegration Specifications: above the time expected.
Lots: Lot#: PWXT, Exp 1/31/2027
Quantity: 3,640 bottles
Distribution: CA and HI
RxNorm: magnesium aluminosilicates, magnesium hydroxide, simethicone (RxCUI 1235450, 1235456)
Recall number: D-0298-2026

Class III · Posted February 4, 2026 · Started December 15, 2025 · Ongoing

glycopyrrolate

Product: Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72
Firm: NOVADOZ PHARMACEUTICALS LLC, Piscataway, NJ
Reason: Failed Impurities/Degradation Specifications
Lots: Lot # CB2505159A, CB2505160A, Exp Date: 04/2027; Lot # CB2505161A, Exp Date: 05/2027
Distribution: US Nationwide.
RxNorm: glycopyrrolate (RxCUI 999961)
Recall number: D-0300-2026

Source: openFDA drug enforcement reports, as of October 14, 2026. Publisher page

About this data

Each row is one FDA drug enforcement report: one product from one firm. A week here is Monday to Sunday, keyed on the date FDA listed the recall in its weekly Enforcement Report. The date the firm started the recall is shown on each row and is often weeks earlier.

Class I means use of the product could cause serious health problems or death. Class II means it could cause temporary or reversible health problems. Class III means it is unlikely to cause health problems. RxNorm names and RxCUIs come from openFDA's match of the product to its drug label. Compounded products often have no match.

This page lists public records. It is not medical advice. Check the FDA record before acting on a recall.